Aptose Biosciences Inc.
APTO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $30 | $515 | $803 | $1,803 |
| - Cash | $6 | $9 | $37 | $39 |
| + Debt | $11 | $1 | $1 | $1 |
| Enterprise Value | $35 | $506 | $767 | $1,765 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$52 | -$42 | -$65 |
| % Margin | – | – | – | – |
| Net Income | -$25 | -$51 | -$42 | -$65 |
| % Margin | – | – | – | – |
| EPS Diluted | -18.94 | -27.08 | -22.12 | -34.56 |
| % Growth | 30.1% | -22.4% | 36% | – |
| Operating Cash Flow | -$36 | -$45 | -$32 | -$43 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$36 | -$45 | -$32 | -$44 |